DIN 02564955 — AURO-MIRABEGRON 50 MG
AURO-MIRABEGRON is a tablet (extended-release) of Mirabegron marketed by AURO PHARMA INC. The full Mirabegron monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02564955
- Brand name
- AURO-MIRABEGRON
- Active ingredient
- Mirabegron
- Strength
- 50 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- AURO PHARMA INC
- Health Canada status
- MARKETED
- Drug class
- Selective beta-3 adrenoceptor agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mirabegron products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02564963 | APO-MIRABEGRON | 25 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02564971 | APO-MIRABEGRON | 50 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02402874 | MYRBETRIQ | 25 MG | TABLET (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |
| 02402882 | MYRBETRIQ | 50 MG | TABLET (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |